Two teams publish DNA-guided CRISPR-Cas12 systems in Nature Biotechnology, inverting the RNA-guide paradigm for RNA diagnostics and antivirals
Researchers at the University of Florida and the Hong Kong University of Science and Technology each report a DNA-guided CRISPR-Cas12 platform that targets RNA, reducing off-target effects and enabling attomolar-level pathogen detection.